SCHEMBL841016

SCHEMBL841016

CC(C)(C)OCc1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
USP2 O75604 3/20 0.60
POLB P06746 2/20 0.60
ATM Q13315 1/20 0.60
PLEC Q15149 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 3/20 0.47
TP53 P04637 2/20 0.47
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ALPL P05186 1/20 0.47
ALPI P09923 1/20 0.47
ALPG P10696 1/20 0.47
CA9 Q16790 8/20 0.43
CA1 P00915 6/20 0.43
CA2 P00918 6/20 0.43
CA12 O43570 4/20 0.43
DNASE1L3 Q13609 1/20 0.42
PRMT1 Q99873 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12708320 0.87 MEN1 (0.68) MEN1KMT2AUSP2POLBATM
SCHEMBL14433567 0.85 MEN1 (0.68) MEN1KMT2AUSP2POLBATM
SCHEMBL840985 0.84 USP2 (0.59) MEN1KMT2AUSP2POLBATM
SCHEMBL15305308 0.84 MEN1 (0.61) MEN1KMT2AUSP2POLBATM
SCHEMBL840925 0.83 MEN1 (0.40) MEN1KMT2AUSP2POLBATM
SCHEMBL8930410 0.82 MEN1 (0.74) MEN1KMT2AUSP2POLBATM
SCHEMBL23463081 0.81 MEN1 (0.67) MEN1KMT2AUSP2POLBATM
SCHEMBL5468848 0.80 USP2 (0.71) MEN1KMT2AUSP2POLBATM
SCHEMBL12909284 0.79 USP2 (0.67) MEN1KMT2AUSP2POLBATM
SCHEMBL20411332 0.79 MEN1 (0.57) MEN1KMT2AUSP2POLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143069-B2 useful for selective measurement of hypochlorite ion; does not react with hydrogen peroxide which is a weakly reactive oxygen species, and does not induce increase of fluorescence with hydroxyl radical or peroxynitrite which are reactive oxygen species having high activity THE UNIVERSITY OF TOKYO (JP) 2012-03-27 US disclosed
US-20090317914-A1 FLUORESCENT PROBE THE UNIVERSITY OF TOKYO (JP) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090317914-A1 FLUORESCENT PROBE H1-10, H1-0, NHERF1 MEN1 444/4885KMT2A 2962/4885USP2 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.